Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
MMMiniMed Group, Inc. logo

MiniMed Group, Inc. (MMED)

NASDAQ Global Select · Currency in USD
$18.34 ▲ +0.05 (+0.27%)
At close: Oct 23, 4:00 PM ET. Market closed.
$18.34 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$18.29
Open
$18.47
Day's Range
$17.94 – $18.47
52 Week Range
$10.65 – $24.43
Volume
4,794,122
Avg. Volume
5,127,760
Market Cap
$5.16B
Beta (5Y Monthly)
-3.71
PE Ratio (TTM)
--
EPS (TTM)
-$1.17
Earnings Date
Dec 30, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$25.73

Profile: MiniMed Group, Inc.

Sector
Healthcare
Industry
Medical - Equipment & Services
Full-time employees
8,000
CEO
Que Thanh Dallara

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels.

Earnings

Next report: Wed, Dec 30, 2026
EPS estimate $0.12 · Revenue est. $825.20M
DateEst.Actual
Sep 1, 2026$0.12$0.12Miss
Jun 3, 2026-$0.15-$0.68Miss
Apr 17, 2026$0.17-$0.16Miss

Analyst view

Consensus price target
$25.73 ▲ +40.3%
Range $16.00 – $30.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on MMED and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.